Zealand Pharma AS (ZLDPF)
135.65
+2.24
(+1.68%)
USD |
OTCM |
Sep 20, 16:00
Zealand Pharma 1 Year Total Returns (Daily): 225.1% for Sept. 20, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 20, 2024 | 225.1% |
| September 19, 2024 | 219.8% |
| September 18, 2024 | 219.8% |
| September 17, 2024 | 222.9% |
| September 16, 2024 | 222.9% |
| September 13, 2024 | 227.8% |
| September 12, 2024 | 228.1% |
| September 11, 2024 | 231.1% |
| September 10, 2024 | 223.1% |
| September 09, 2024 | 221.2% |
| September 06, 2024 | 239.2% |
| September 05, 2024 | 232.7% |
| September 04, 2024 | 243.2% |
| September 03, 2024 | 237.8% |
| August 30, 2024 | 220.6% |
| August 29, 2024 | 220.6% |
| August 28, 2024 | 220.6% |
| August 27, 2024 | 224.4% |
| August 26, 2024 | 224.4% |
| August 23, 2024 | 227.1% |
| August 22, 2024 | 230.9% |
| August 21, 2024 | 278.9% |
| August 20, 2024 | 276.5% |
| August 19, 2024 | 282.5% |
| August 16, 2024 | 301.0% |
| Date | Value |
|---|---|
| August 15, 2024 | 287.5% |
| August 14, 2024 | 287.6% |
| August 13, 2024 | 276.2% |
| August 12, 2024 | 255.7% |
| August 09, 2024 | 289.9% |
| August 08, 2024 | 277.9% |
| August 07, 2024 | 277.0% |
| August 06, 2024 | 271.3% |
| August 05, 2024 | 254.8% |
| August 02, 2024 | 293.2% |
| August 01, 2024 | 293.2% |
| July 31, 2024 | 298.0% |
| July 30, 2024 | 296.0% |
| July 29, 2024 | 277.3% |
| July 26, 2024 | 286.7% |
| July 25, 2024 | 305.9% |
| July 24, 2024 | 271.6% |
| July 23, 2024 | 256.5% |
| July 22, 2024 | 251.0% |
| July 19, 2024 | 248.5% |
| July 18, 2024 | 245.5% |
| July 17, 2024 | 272.1% |
| July 16, 2024 | 302.6% |
| July 15, 2024 | 300.2% |
| July 12, 2024 | 298.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-65.83%
Minimum
May 11 2022
305.9%
Maximum
Jul 25 2024
69.52%
Average
68.14%
Median
Dec 01 2023
1 Year Total Returns (Daily) Benchmarks
| Novo Nordisk AS | 36.10% |
| Eli Lilly and Co | 62.84% |
| Altimmune Inc | 188.5% |
| Genmab AS | -31.79% |
| Viking Therapeutics Inc | 422.9% |